Skip to content

Product information

Product name
Clarinase Repetabs 120 mg - 5 mg
Pack
14
Active ingredient
pseudo-efedrine + loratadine
CNK Code
0482778
Availability score
0 / 10
Historic availability score
Locked

Product properties

CAS code
7460-12-0
ATC code
R01BA52, R06AX13
Company
Bayer
Pharmaceutical form
Prolonged-release tablet
Ex-factory price
Authorisation number
BE152826
GTIN
04057599000634
Delivery mode
TD
Delivery environment
Public
CTI Extended
152826-04

Pharmacist Assessment

Assessment title
Commercialization officially ended — no stock
Assessment description

SAM has flagged this product as commercially stopped (reason: Replacement by another medicinal product/pack) and no stock is available from wholesalers. Switching to an alternative is necessary.

Recommended alternative

Assessment alternative
Clarinase Repetabs 120 mg - 5 mg (CNK 5801998) — Score: 9.26/10

Equivalent products

Tier A: Direct equivalents

…

Tier B: Galenic alternatives

…

Tier C: Strength alternatives

…

Tier D: ATC equivalents (parallel import)

…

Tier E: Active substances (magistral)

…

Stock overview

Availability in Freemium
  • 0 of 18 warehouse locations have stock
  • 0 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Available alternatives
Parallel import available 3 Magistral alternative available 2

Status history (PharmaStatus)

Commercialization stopped Active
- present

Replacement by another medicinal product/pack

Adaptation of the treatment possible (non-vital medicinal product)
Available
Until 31/05/2026

Composition

4 ingredients

Ingredients
Substance Type Strength CAS
Substance
Loratadine
Type
Active ingredient
Strength
5 mg
CAS
79794-75-5
Substance
Pseudo-efedrinesulfaat
Type
Active ingredient
Strength
120 mg
CAS
7460-12-0
Substance
Lactose
Type
Excipient
Strength
156.8 mg
CAS
Substance
Sucrose
Type
Excipient
Strength
173.6 mg
CAS

Additional information

Leaflet
Download leaflet
SPC
Download SPC
BCPI
View on BCPI
PharmaStatus
View on PharmaStatus

Availability statistics

Current status
Commercialization stopped
Days unavailable (last year)
600 days
Number of status changes
7
Active supply problems
0
Last change
01/06/2026